Buckingham Research Upgrades Par Pharmaceutical (PRX) to Buy
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 21 | New: 48
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 21 | New: 48
Join SI Premium – FREE
Buckingham Research upgraded Par Pharmaceutical (NYSE: PRX)from Neutral to Buy with a new price target of $45.00.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $34.01 yesterday.
For an analyst ratings summary and ratings history on Par Pharmaceutical click here. For more ratings news on Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $34.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades First Solar (FSLR) to Buy
- Erste Group Upgrades Meta Platforms Inc. (META) to Buy
- Benchmark Upgrades Repligen (RGEN) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Buckingham ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
